Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

196 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans.
Nauck MA, Kemmeries G, Holst JJ, Meier JJ. Nauck MA, et al. Among authors: meier jj. Diabetes. 2011 May;60(5):1561-5. doi: 10.2337/db10-0474. Epub 2011 Mar 23. Diabetes. 2011. PMID: 21430088 Free PMC article. Clinical Trial.
Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.
Meier JJ, Hücking K, Holst JJ, Deacon CF, Schmiegel WH, Nauck MA. Meier JJ, et al. Diabetes. 2001 Nov;50(11):2497-504. doi: 10.2337/diabetes.50.11.2497. Diabetes. 2001. PMID: 11679427
Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives.
Meier JJ, Gallwitz B, Schmidt WE, Nauck MA. Meier JJ, et al. Eur J Pharmacol. 2002 Apr 12;440(2-3):269-79. doi: 10.1016/s0014-2999(02)01434-6. Eur J Pharmacol. 2002. PMID: 12007541 Review.
Gastric inhibitory polypeptide: the neglected incretin revisited.
Meier JJ, Nauck MA, Schmidt WE, Gallwitz B. Meier JJ, et al. Regul Pept. 2002 Jul 15;107(1-3):1-13. doi: 10.1016/s0167-0115(02)00039-3. Regul Pept. 2002. PMID: 12137960 Review.
Combined pancreas and kidney transplantation in a lean type 2 diabetic patient. Effects on insulin secretion and sensitivity.
Pox C, Ritzel R, Büsing M, Meier JJ, Klempnauer J, Schmiegel W, Nauck MA. Pox C, et al. Among authors: meier jj. Exp Clin Endocrinol Diabetes. 2002 Nov;110(8):420-4. doi: 10.1055/s-2002-36429. Exp Clin Endocrinol Diabetes. 2002. PMID: 12518254
Glucagon-like peptide 1 and gastric inhibitory polypeptide: potential applications in type 2 diabetes mellitus.
Meier JJ, Gallwitz B, Nauck MA. Meier JJ, et al. BioDrugs. 2003;17(2):93-102. doi: 10.2165/00063030-200317020-00002. BioDrugs. 2003. PMID: 12641488 Review.
The reduction in hepatic insulin clearance after oral glucose is not mediated by gastric inhibitory polypeptide (GIP).
Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, Nauck MA. Meier JJ, et al. Regul Pept. 2003 May 15;113(1-3):95-100. doi: 10.1016/s0167-0115(02)00297-5. Regul Pept. 2003. PMID: 12686467 Clinical Trial.
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia.
Meier JJ, Gallwitz B, Siepmann N, Holst JJ, Deacon CF, Schmidt WE, Nauck MA. Meier JJ, et al. Diabetologia. 2003 Jun;46(6):798-801. doi: 10.1007/s00125-003-1103-y. Epub 2003 May 23. Diabetologia. 2003. PMID: 12764578
Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes.
Meier JJ, Gallwitz B, Salmen S, Goetze O, Holst JJ, Schmidt WE, Nauck MA. Meier JJ, et al. J Clin Endocrinol Metab. 2003 Jun;88(6):2719-25. doi: 10.1210/jc.2003-030049. J Clin Endocrinol Metab. 2003. PMID: 12788879 Clinical Trial.
Incretins and their analogues as new antidiabetic drugs.
Nauck MA, Meier JJ, Creutzfeldt W. Nauck MA, et al. Among authors: meier jj. Drug News Perspect. 2003 Sep;16(7):413-22. doi: 10.1358/dnp.2003.16.7.829353. Drug News Perspect. 2003. PMID: 14668937 Review.
196 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback